Immuneering CorporationIMRXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P83
Within normal range
vs 2Y Ago
8.5x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 17.84% |
| Q3 2025 | -26.80% |
| Q2 2025 | 32.91% |
| Q1 2025 | 2.96% |
| Q4 2024 | -7.71% |
| Q3 2024 | -16.88% |
| Q2 2024 | 25.60% |
| Q1 2024 | -31.56% |
| Q4 2023 | 2.09% |
| Q3 2023 | -11.89% |
| Q2 2023 | 25.45% |
| Q1 2023 | -22.72% |
| Q4 2022 | -10.60% |
| Q3 2022 | -12.41% |
| Q2 2022 | 23.06% |
| Q1 2022 | -32.93% |
| Q4 2021 | -2.26% |
| Q3 2021 | -40.35% |
| Q2 2021 | -4.85% |
| Q1 2021 | -12.59% |
| Q4 2020 | -56.43% |
| Q3 2020 | -3.53% |
| Q2 2020 | -45.50% |
| Q1 2020 | 0.00% |